Hyundai Pharm (004310) - Cash Flow Conversion Efficiency

Latest as of May 2025: -0.038x

Based on the latest financial reports, Hyundai Pharm (004310) has a cash flow conversion efficiency ratio of -0.038x as of May 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.99 Billion ≈ $-2.03 Million USD) by net assets (₩77.99 Billion ≈ $52.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hyundai Pharm - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Hyundai Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Hyundai Pharm for a breakdown of total debt and financial obligations.

Hyundai Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hyundai Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Modiv Inc NYSE:MDV	0.020x
Ryvu Therapeutics SA WAR:RVU	-0.522x
Merafe JSE:MRF	-0.033x
Ecomate Holdings Bhd KLSE:0239	-0.103x
Laramide Resources Ltd AU:LAM	-0.017x
Euroapi SAS PA:EAPI	0.018x
Duta Intidaya Tbk PT JK:DAYA	-0.595x
msg life ag HM:MSGL	-0.019x

Annual Cash Flow Conversion Efficiency for Hyundai Pharm (2010–2024)

The table below shows the annual cash flow conversion efficiency of Hyundai Pharm from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Hyundai Pharm market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-11-30	₩79.07 Billion ≈ $53.59 Million	₩-2.37 Billion ≈ $-1.61 Million	-0.030x	+44.10%
2023-11-30	₩84.66 Billion ≈ $57.37 Million	₩-4.55 Billion ≈ $-3.08 Million	-0.054x	-139.98%
2022-11-30	₩86.56 Billion ≈ $58.66 Million	₩11.62 Billion ≈ $7.88 Million	0.134x	+126.60%
2021-11-30	₩86.60 Billion ≈ $58.69 Million	₩5.13 Billion ≈ $3.48 Million	0.059x	-50.56%
2020-11-30	₩90.14 Billion ≈ $61.09 Million	₩10.80 Billion ≈ $7.32 Million	0.120x	+50.79%
2019-11-30	₩87.58 Billion ≈ $59.35 Million	₩6.96 Billion ≈ $4.72 Million	0.079x	+200.09%
2018-11-30	₩107.00 Billion ≈ $72.52 Million	₩2.83 Billion ≈ $1.92 Million	0.026x	+231.16%
2017-11-30	₩98.10 Billion ≈ $66.48 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.020x	+26.42%
2016-11-30	₩100.08 Billion ≈ $67.82 Million	₩-2.75 Billion ≈ $-1.86 Million	-0.027x	-134.94%
2013-11-30	₩101.21 Billion ≈ $68.59 Million	₩7.95 Billion ≈ $5.39 Million	0.079x	+390.34%
2012-11-30	₩99.69 Billion ≈ $67.56 Million	₩-2.70 Billion ≈ $-1.83 Million	-0.027x	-145.03%
2011-11-30	₩104.32 Billion ≈ $70.69 Million	₩6.27 Billion ≈ $4.25 Million	0.060x	+107.53%
2010-11-30	₩92.50 Billion ≈ $62.69 Million	₩2.68 Billion ≈ $1.82 Million	0.029x	--

About Hyundai Pharm

KO:004310 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$152.68 Million

₩225.29 Billion KRW

Market Cap Rank

#17580 Global

#827 in Korea

Share Price

₩8620.00

Change (1 day)

-3.25%

52-Week Range

₩3310.00 - ₩14340.00

All Time High

₩14340.00